IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

Abstract There are considerable new data on mutation topography in persons with myelodysplastic syndromes (MDS). These data have been used to update conventional risk models such as the Revised International Prognostic Scoring System (IPSS-R). Whether the molecular IPSS (IPSS-M) which includes these...

Full description

Bibliographic Details
Main Authors: Junying Wu, Yudi Zhang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Yujiao Jia, Chengwen Li, Huijun Wang, Qingyan Gao, Wenyu Cai, Jingye Gong, Songyang Zhao, Fuhui Li, Robert Peter Gale, Zhijian Xiao
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Experimental Hematology & Oncology
Subjects:
Myelodysplastic syndrome
Prognostic model
Patient age
Mutation profile
Online Access:https://doi.org/10.1186/s40164-022-00328-4

Internet

https://doi.org/10.1186/s40164-022-00328-4

Similar Items